about
Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.Impact of null genotypes of GSTT1 and GSTM1 with uterine leiomyoma risk in Iranian population.Translation and validation of the Uterine Fibroid Symptom and Quality of Life (UFS-QOL) questionnaire for the Brazilian Portuguese language.Screening of potential biomarkers in uterine leiomyomas disease via gene expression profiling analysis.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacological treatment of uterine fibroids.
@ast
Pharmacological treatment of uterine fibroids.
@en
Pharmacological treatment of uterine fibroids.
@nl
type
label
Pharmacological treatment of uterine fibroids.
@ast
Pharmacological treatment of uterine fibroids.
@en
Pharmacological treatment of uterine fibroids.
@nl
prefLabel
Pharmacological treatment of uterine fibroids.
@ast
Pharmacological treatment of uterine fibroids.
@en
Pharmacological treatment of uterine fibroids.
@nl
P2093
P2860
P356
P1476
Pharmacological treatment of uterine fibroids
@en
P2093
P2860
P304
P356
10.4103/2141-9248.141955
P433
P577
2014-09-01T00:00:00Z